1. Home
  2. AIO vs CTKB Comparison

AIO vs CTKB Comparison

Compare AIO & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIO
  • CTKB
  • Stock Information
  • Founded
  • AIO 2019
  • CTKB 1990
  • Country
  • AIO United States
  • CTKB United States
  • Employees
  • AIO N/A
  • CTKB N/A
  • Industry
  • AIO Finance/Investors Services
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • AIO Finance
  • CTKB Health Care
  • Exchange
  • AIO Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • AIO 865.4M
  • CTKB 718.8M
  • IPO Year
  • AIO N/A
  • CTKB 2021
  • Fundamental
  • Price
  • AIO $24.64
  • CTKB $5.12
  • Analyst Decision
  • AIO
  • CTKB Strong Buy
  • Analyst Count
  • AIO 0
  • CTKB 2
  • Target Price
  • AIO N/A
  • CTKB $9.25
  • AVG Volume (30 Days)
  • AIO 141.5K
  • CTKB 747.0K
  • Earning Date
  • AIO 01-01-0001
  • CTKB 02-27-2025
  • Dividend Yield
  • AIO 9.05%
  • CTKB N/A
  • EPS Growth
  • AIO N/A
  • CTKB N/A
  • EPS
  • AIO N/A
  • CTKB N/A
  • Revenue
  • AIO N/A
  • CTKB $201,210,000.00
  • Revenue This Year
  • AIO N/A
  • CTKB $7.26
  • Revenue Next Year
  • AIO N/A
  • CTKB $8.20
  • P/E Ratio
  • AIO N/A
  • CTKB N/A
  • Revenue Growth
  • AIO N/A
  • CTKB 9.88
  • 52 Week Low
  • AIO $15.09
  • CTKB $4.66
  • 52 Week High
  • AIO $20.25
  • CTKB $9.33
  • Technical
  • Relative Strength Index (RSI)
  • AIO 46.34
  • CTKB 37.48
  • Support Level
  • AIO $25.01
  • CTKB $5.18
  • Resistance Level
  • AIO $25.45
  • CTKB $5.48
  • Average True Range (ATR)
  • AIO 0.44
  • CTKB 0.27
  • MACD
  • AIO -0.05
  • CTKB 0.01
  • Stochastic Oscillator
  • AIO 31.37
  • CTKB 27.85

About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: